Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Naloxone benzoylhydrazone is an antagonist of μ-, κ1-, and δ-opioid receptors (pA2s = 8.82, 7.45, and 7.76, respectively, for the mouse receptors).1 It is also an agonist of the κ3-opioid receptor (IC50 = 0.7 nM for the guinea pig receptor). Naloxone benzoylhydrazone (1 µg/animal, i.c.v.) inhibits increases in the latency to tail withdrawal induced by the μ-opioid receptor agonist DAMGO (Item No. 21553) in a hot plate assay in mice.2 It increases food intake in rats when intracerebrally administered at doses of 0.1, 1, and 20 µg/animal.3
WARNING This product is not for human or veterinary use.
1. The in vitro pharmacological characterization of naloxone benzoylhydrazone. Eur. J. Pharmacol. 277(2-3), 257-263 (1995).
2. Naloxone benzoylhydrazone (NalBzoH) analgesia. J. Pharmacol. Exp. Ther. 255(2), 769-774 (1990).
3. Naloxone benzoylhydrazone, a ᴋ3 opioid agonist, stimulates food intake in rats. Brain. Res. 581(2), 311-314 (1992).